SureTrader SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

Fidelity says PVCT is invalid symbol now. Anyone

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
smt232 Member Profile
 
Followed By 0
Posts 41
Boards Moderated 0
Alias Born 01/15/14
160x600 placeholder
Advertisement
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 9/1/2015 5:02:40 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 8/21/2015 4:34:09 PM
Provectus Biopharmaceuticals Awarded US Patent Protecting Use of PV-10 as Part of Combination Therapy for Cancer "Business Wire" - 8/18/2015 9:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/18/2015 9:17:04 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/6/2015 6:37:36 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2015 6:12:19 AM
Provectus Biopharmaceuticals Reports Second Quarter 2015 Financial Results "Business Wire" - 8/6/2015 6:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/28/2015 6:01:39 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/22/2015 6:05:39 AM
Provectus Biopharmaceuticals Will Hold Its 2015 Second Quarter Bus. Update Conference Call on Thursday, August 6, 2015, at 4 ... "Business Wire" - 7/22/2015 6:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 7/16/2015 5:04:19 PM
Provectus Biopharmaceuticals, Sinopharm-China State Institute of Pharmaceutical Industry & Sinopharm A-Think Pharmaceutical C... "Business Wire" - 7/15/2015 5:33:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/15/2015 5:18:57 PM
Provectus Biopharmaceuticals’ Phase 1 PV-10 Data on Liver Cancer Presented at 6th Asia-Pacific Primary Liver Cancer Expert ... "Business Wire" - 7/6/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/6/2015 7:41:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/2/2015 6:32:53 AM
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim (China) to Collaborate in Bringing PV-10 to Mar... "Business Wire" - 7/2/2015 6:30:00 AM
Provectus Biopharmaceuticals’ Data on PV-10 for Chemoablation of Liver Cancers Presented at ESMO 17th World Congress on Gas... "Business Wire" - 7/2/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/26/2015 9:01:52 AM
AAPI Honors Provectus Biopharmaceuticals During 33rd Annual Convention and Scientific Assembly "Business Wire" - 6/26/2015 9:00:00 AM
Provectus Biopharmaceuticals’ Data on PV-10 as Treatment for Melanoma Presented at 5th European Post-Chicago Melanoma / Ski... "Business Wire" - 6/26/2015 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/25/2015 8:02:47 AM
Provectus Biopharmaceuticals’ Poster Presentation Displayed on Phase 3 Study of PV-10 at 5th European Post-Chicago Melanoma... "Business Wire" - 6/25/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/24/2015 4:03:19 PM
Provectus Biopharmaceuticals Announces Abstract Available on PV-10 for Chemoablation of Liver Cancers at ESMO 17th World Cong... "Business Wire" - 6/24/2015 4:02:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist